Tailored advisory services for biotech companies – from modular support to full process management
Finding the right acquisition target in the life sciences sector can be difficult. Many opportunities never reach the open market, and assessing the scientific, commercial, and strategic fit of a company requires sector-specific understanding.
Pivotal Scientific supports life science companies with buy-side mergers and acquisitions strategy, target identification, and transaction support. Our team combines commercial and technical expertise with established relationships across the life sciences industry to help buyers identify and secure the right opportunities.
Inorganic framework development
- Acquisition strategy
- Assessment of market landscape, sizing, competition and opportunity
- Expertise across all segment domains (antibodies, proteins, research reagents & kits, IVD, cells, media and novel technologies)
Target list development & analysis
- Long list generation – formulated to pre-agreed criteria in line with your strategic goals
- Short list generation – down-selection to optimised targets, deep dives, multi-target acquisition strategy (e.g. bolt-ons/ platforms)
Approach to candidate companies
- Direct approach to confirm target addressability, obtain additional financial data to refine target valuation, and manage additional data requests e.g. employees, product, IP
- Approach tailored to your messaging
- Blind approach upon request
Completion – from offer to deal closure
- From full scope support/ deal management to modular advisory services
- Support across deal structure, commercial due diligence (technical, go-to-market, contracts) and project implementation/ integration
Why Buy-Side M&A in Life Sciences Is Challenging
Acquisition decisions in life sciences require more than financial analysis alone. Scientific credibility, product fit, market position, channel strength, and founder motivations all influence whether an acquisition creates long-term value.
Challenges often include:
- Limited visibility of suitable acquisition targets
- Difficulty accessing owner-operated businesses
- Assessing commercial potential within niche scientific markets
- Understanding technical differentiation and IP position
- Managing acquisition activity alongside day-to-day operations
- We support buyers through these challenges with a structured, sector-focused approach.
We support buyers through these challenges with a structured, sector-focused approach.
Your Trusted Partner in Biotech Acquisitions
Our team has worked across the life sciences sector for more than a decade, supporting transactions. We can support strategic buyers and private equity-backed businesses across a range of industries, including antibodies and assays, life science tools, and diagnostic and IVD companies. Our relationships with owners across the sector allow us to identify opportunities that may not yet be publicly marketed.
Whether you are pursuing a specific acquisition or exploring growth opportunities within life sciences, we can support different stages of the process.
- Strategic direction derivation
- Acquisition targeting – Long list generation
- Acquisition targeting – Short list down select
- Approach potential vendors with your tailored message leveraging our access to an extensive network of life science companies (can be blind)
- Transaction support (Commercial Due Diligence, Expert advisory, Strategic plans)
